Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Idiopathic recurrent stupor is a rare neurologic disease characterized by unpredictable, transient and spontaneous unresponsiveness lasting from hours to days, with a frequency of three to seven attacks per year, in the absence of readily discernible toxic, metabolic or structural causes.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for idiopathic recurrent stupor.
4 publications have been identified in PubMed for idiopathic recurrent stupor. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (25%), and Clinical Trial Publication (25%).
Garcia-Santos RA (2026). [PMID: 41737123](https://pubmed.ncbi.nlm.nih.gov/41737123/). *Cureus*. [Case Report / Case Series]
Picard-Deland C (2025). [PMID: 40387303](https://pubmed.ncbi.nlm.nih.gov/40387303/). *Journal of sleep research*. [Review / Meta-Analysis]
Harbaugh TD (2025). [PMID: 40034632](https://pubmed.ncbi.nlm.nih.gov/40034632/). *Cureus*. [Clinical Trial Publication]
Taylor S (2025). [PMID: 39935081](https://pubmed.ncbi.nlm.nih.gov/39935081/). *Journal of feline medicine and surgery*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:12 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning idiopathic recurrent stupor
Updated Sep 14, 2026
Research indicates that goflikicept may modulate immune responses in patients with idiopathic recurrent pericarditis, as revealed by single-cell RNA profiling. This study could pave the way for new therapeutic strategies in managing this condition.
Researchers have identified novel serum proteins that differentiate idiopathic recurrent aphthous stomatitis from Behcet's disease. This discovery could enhance diagnostic accuracy and improve patient management for these conditions.